NDC properties for NDC 9 0025-0317
NDC item 00025031701
| NDC 9 | 0025-0317 |
|---|---|
| NDC 10 | 0025-0317-01 |
| NDC Item | 00025031701 |
| packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | active |
NDC item 00025032801
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-01 |
| NDC Item | 00025032801 |
| packaging | 1 KIT in 1 CARTON (0025-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
NDC item 00025032802
| NDC 9 | 0025-0328 |
|---|---|
| NDC 10 | 0025-0328-02 |
| NDC Item | 00025032802 |
| packaging | 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785870 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-12-14 |
| Marketing status | ACTIVE |
NDC item 00069031701
| NDC 9 | 0069-0317 |
|---|---|
| NDC 10 | 0069-0317-01 |
| NDC Item | 00069031701 |
| packaging | 0.8 mL in 1 SYRINGE |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | active |
NDC item 00069032801
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-01 |
| NDC Item | 00069032801 |
| packaging | 1 KIT in 1 CARTON (0069-0328-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |
NDC item 00069032802
| NDC 9 | 0069-0328 |
|---|---|
| NDC 10 | 0069-0328-02 |
| NDC Item | 00069032802 |
| packaging | 2 KIT in 1 CARTON (0069-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0069-0317-01) * 1 mL in 1 PACKET (0069-1111-01) |
| BLA | BLA761118 |
| FDA SPL set id | 785892 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-10-18 |
| Marketing status | ACTIVE |